These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10446611)

  • 1. [Erectile dysfunction: an educational program].
    Jiménez Mayorga IE; Soto Jiménez T
    Rev Enferm; 1999 Feb; 22(2):151-5. PubMed ID: 10446611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic erection program: an alternative solution for the man with erectile dysfunction.
    Grégoire I
    Urol Nurs; 1995 Mar; 15(1):10-3. PubMed ID: 7792617
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study.
    Latini DM; Penson DF; Lubeck DP; Wallace KL; Henning JM; Lue TF
    J Urol; 2003 Apr; 169(4):1437-42. PubMed ID: 12629379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PGE1 program in erectile dysfunction: etiopathogenic and pharmacologic aspects].
    Ruiz Rubio JL; Fernández González I; Ruiz Rojas JC; Sánchez Sánchez E; Bustamante Alarma S; Berenguer Sánchez A
    Actas Urol Esp; 1996; 20(7):636-9. PubMed ID: 8975549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavernosal injection therapy: a practical guide.
    Mulhall JP
    Tech Urol; 1997; 3(3):129-34. PubMed ID: 9422443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment program for erectile dysfunction in patients with cardiovascular diseases.
    Israilov S; Baniel J; Shmueli J; Niv E; Engelstein D; Segenreich E; Livne PM
    Am J Cardiol; 2004 Mar; 93(6):689-93. PubMed ID: 15019870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Teaching the patient about intra-cavernous injections to prevent erectile dysfunction].
    Héron M
    Soins; 2007 Mar; (713):50-1. PubMed ID: 17419575
    [No Abstract]   [Full Text] [Related]  

  • 9. Newer pharmacologic alternatives for erectile dysfunction.
    Viera AJ; Clenney TL; Shenenberger DW; Green GF
    Am Fam Physician; 1999 Sep; 60(4):1159-66, 1169, 1172. PubMed ID: 10507745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of erectile dysfunction in multiple sclerosis.
    Landtblom AM
    Expert Rev Neurother; 2006 Jun; 6(6):931-5. PubMed ID: 16784415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavernosal injection algorithm.
    Albaugh JA
    Urol Nurs; 2006 Dec; 26(6):449-53. PubMed ID: 17253079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
    Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
    Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
    Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and compliance of MUSE for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
    Raina R; Agarwal A; Zaramo CE; Ausmundson S; Mansour D; Zippe CD
    Int J Impot Res; 2005; 17(1):86-90. PubMed ID: 15526008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erectile dysfunction].
    Lyngdorf P
    Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on oral treatments for male erectile dysfunction.
    Kalsi JS; Kell PD
    J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.